Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcium channel protein alpha 1C subunit (CACNA1C) is a critical component of voltage-dependent L-type calcium channels. These channels mediate calcium influx upon membrane depolarization and are essential for numerous physiological processes, including cardiac action potentials, neurotransmitter release, and muscle contraction. Mutations in CACNA1C are associated with several disorders, including Timothy Syndrome and Long QT Syndrome type 8.
Inhibition of calcium channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium channel protein alpha 1C subunit (CaV₁.₂).